Pereira Patrícia, Pedro Augusto Q, Tomás Joana, Maia Cláudio J, Queiroz João A, Figueiras Ana, Sousa Fani
CICS-UBI-Health Sciences Research Centre, University of Beira Interior, Avenida Infante D. Henrique, 6200-506, Covilhã, Portugal.
CNC-Center of Neuroscience and Cell Biology, University of Coimbra, Largo Marquês de Pombal, 3004-517, Coimbra, Portugal.
Appl Microbiol Biotechnol. 2016 Apr;100(8):3723-34. doi: 10.1007/s00253-016-7350-x. Epub 2016 Feb 10.
The present study reports the successful production of human pre-miR-29b both intra- and extracellularly in the marine phototrophic bacterium Rhodovulum sulfidophilum using recombinant RNA technology. In a first stage, the optimal transformation conditions (0.025 μg of plasmid DNA, with a heat-shock of 2 min at 35 °C) were established, in order to transfer the pre-miR-29b encoding plasmid to R. sulfidophilum host. Furthermore, the extracellular recovery of this RNA product from the culture medium was greatly improved, achieving quantities that are compatible with the majority of applications, namely for in vitro or in vivo studies. Using this system, the extracellular human pre-miR-29b concentration was approximately 182 μg/L, after 40 h of bacterial growth, and the total intracellular pre-miR-29b was of about 358 μg/L, at 32 h. At the end of the fermentation, it was verified that almost 87 % of cells were viable, indicating that cell lysis is minimized and that the extracellular medium is not highly contaminated with the host intracellular ribonucleases (RNases) and endotoxins, which is a critical parameter to guarantee the microRNA (miRNA) integrity. These findings demonstrate that pre-miRNAs can be produced by recombinant RNA technology, offering novel clues for the production of natural pre-miRNA agents for functional studies and RNA interference (RNAi)-based therapeutics.
本研究报告了利用重组RNA技术在嗜硫小红卵菌中成功实现人pre-miR-29b的胞内和胞外生产。在第一阶段,确定了最佳转化条件(0.025μg质粒DNA,35°C热休克2分钟),以便将编码pre-miR-29b的质粒转入嗜硫小红卵菌宿主。此外,从培养基中回收该RNA产物的胞外回收率得到了极大提高,获得的产量与大多数应用(即体外或体内研究)相匹配。使用该系统,细菌生长40小时后,胞外人类pre-miR-29b浓度约为182μg/L,32小时时胞内总pre-miR-29b约为358μg/L。发酵结束时,证实近87%的细胞存活,这表明细胞裂解最小化,且胞外培养基未被宿主细胞内核糖核酸酶(RNases)和内毒素高度污染,这是保证微小RNA(miRNA)完整性的关键参数。这些发现表明,pre-miRNAs可通过重组RNA技术生产,为生产用于功能研究的天然pre-miRNA试剂和基于RNA干扰(RNAi)的疗法提供了新线索。